MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Case of Concurrent Wilson Disease and Parkinson Disease

    C. Tapia, M. Davis, M. Penon-Portmann, S. Hahn, E. Rezvanian (Seattle, USA)

    Objective: to present a case of concurrent Wilson disease and Parkinson disease. Background: Wilson disease (WD) is a rare autosomal recessive disease that typically manifests…
  • 2024 International Congress

    New onset movement disorders following COVID-19 infection

    D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

    Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…
  • 2024 International Congress

    The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation

    F. Yazdanian, A. Enriquez-Marulanda, N. Dehmamy, J. Shils, R. Alterman (boston, USA)

    Objective: This study aims to assess the estimated battery longevity and its determinants in Percept model of Deep Brain Stimulation (DBS) devices in patients diagnosed…
  • 2024 International Congress

    Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

    A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

    Objective: The Parkinson’s Foundation made another significant step toward its vision to eliminate preventable harm and promote higher reliability in care with the launch of…
  • 2024 International Congress

    The course of cognitive impairment in Parkinson’s disease patients with Сovid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: A comparative analysis of the characteristics of cognitive impairment in Parkinson's disease patients with and without Сovid-19. Background: Covid-19 infection strongly affects the central…
  • 2024 International Congress

    Walking reduced the risk of Parkinson’s disease dementia: a retrospective longitudinal follow-up study

    CY. Wei, PY. Chiu (Changhua County, Taiwan)

    Objective: We aimed to test whether the minimal amount of exercise (MAE) of walking, which is practical for people with motor dysfunction, could help prevent…
  • 2024 International Congress

    Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data

    M. Schlindwein, A. Franco, J. Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. Bastiani, R. Barros, E. R. Zimmer, A. Schuh (Porto Alegre, Brazil)

    Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…
  • 2024 International Congress

    “This Abstract Presents the Most Important Scientific ___.” A New Sentence Completion Test for Parkinson’s Disease.

    T. Turner, F. Rodriguez-Porcel (Charleston, USA)

    Objective: In this study we examined psychometric properties of a brief language and executive function measure in People with Parkinson’s (PwP) and related disorders. Background:…
  • 2024 International Congress

    Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease

    P. Marcott, A. Nelson (San Francisco, USA)

    Objective: To examine sleep architecture in a commonly studied mouse model of Parkinson’s disease (PD) to better understand underlying circuit mechanisms of sleep disturbances in…
  • 2024 International Congress

    Effect of Orthostatic Hypotension Medications on Orthostatic Ratio: A Systemic Review and Meta-Analysis

    V. Pham, M. Rashid, B. Kung, S. Hossain (Toledo, USA)

    Objective: To review potential effect of common orthostatic hypotension medications on orthostatic ratio Background: Orthostatic ratio, defined as change in heartrate over change in systolic…
  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley